Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination...

por Hauswald, H., Jensen, A.D., Krauss, J., Haselmann, R., Lossner, K., Hartmann, S., Windemuth-Kieselbach, C., Münter, M.W., Debus, J.
Publicado 2018